Company Analysis

iSpecimen Inc. (ISPC)

Nasdaq: ISPC · Services-Commercial Physical & Biological Research · Woburn, MA · filing with the SEC since 2012
Grade3.1
◀ Past 1.4● Present 2.5▶ Future 4.7
3 est.

Who owns iSpecimen Inc.

As filed with the SEC
Holders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
1
report now, of 18 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
OBF Investments, LLC
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock · reported falling below 5%
under 5%
James G. Wolf
SCHEDULE 13G/A · filed Jul 9, 2024 · Common Stock · reported falling below 5%
under 5%
What ISPC reports owning in othersstakes of 5% or more, and other ties
iSpecimen Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2123
2023 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.
SI Assistanton ISPC · research, not advice